General Motors Recognizes World's Foremost Cancer Scientists
DETROIT - Arnold J. Levine, Ph.D., newly appointed president of The Rockefeller University, and Robert G. Roeder, Ph.D., professor and head of the Laboratory of Biochemistry and Molecular Biology, have been recognized by the General Motors Cancer Research Foundation for their major contributions to cancer research.
Dr. Levine was cited for the isolation, cloning, and characterization of the biological properties of the p53 tumor suppressor gene. He will receive the Foundation's Charles S. Mott Prize, which honors the most outstanding recent contribution to the discovery of the cause or ultimate prevention of human cancer.
Dr. Roeder and co-winner Robert Tjian, Ph.D. of the University of California at Berkeley, were cited for their discoveries on the mechanism and regulation of gene transcription in eukaryotic cells. They will share the Alfred P. Sloan Prize, which honors the most outstanding recent basic science contributions to cancer research.
The awards will be presented during a ceremony at the U.S. Department of State in Washington, D.C. on June 9. Each prize consists of $250,000 and a gold medal.
"Breakthroughs in molecular biology are revolutionizing cancer research and laying the foundation for entirely new diagnostics and therapies," said Dr. Samuel A. Wells, Jr., President of the GM Cancer Research Foundation (GMCRF.) He called Drs. Levine and Roeder exemplary scientists and worthy recipients of the Foundation's awards. "The selection of awardees follows a rigorous review process conducted by a panel of prestigious international scientists," he said.
In December 1998, Dr. Levine became head of The Rockefeller University, the
nation's first medical research institute. A member of the National Academy of
Sciences, he has received many honors, including the 1998 Horwitz Prize and
awards from Memorial Sloan-Kettering Cancer Center, Bristol-Myers Squibb,
Contact: Joseph Bonner